“Therapeutic uses of natural astaxanthin: An evidence-based review focused on human clinical trials”
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Astaxanthin is a natural C40 carotenoid with numerous reported biological functions, most of them associated with its antioxidant and anti-inflammatory activity, standing out from other antioxidants as it has shown the highest oxygen radical absorbance capacity (ORAC), 100-500 times higher than ⍺-tocopherol and a 10 times higher free radical inhibitory activity than related antioxidants (α-tocopherol, α-carotene, β -carotene, lutein and lycopene). In vitro and in vivo studies have associated astaxanthin´s unique molecular features with several health benefits, including neuroprotective, cardioprotective and antitumoral properties, suggesting its therapeutic potential for the prevention or co-treatment of dementia, Alzheimer, Parkinson, cardiovascular diseases and cancer. Benefits on skin and eye health promotion have also been reported, highlighting its potential for the prevention of skin photo-aging and the treatment of eye diseases like glaucoma, cataracts and uveitis. In this review, we summarize and discuss the currently available evidence on astaxanthin benefits, with a particular focus on human clinical trials, including a brief description of the potential mechanisms of action responsible for its biological activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750
The role of oxidative stress in neurodegenerative diseases
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355
Astaxanthin: a review of its chemistry and applications
Higuera-Ciapara, I., Félix-Valenzuela, L., & Goycoolea, F. M. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690590957188 · Cited by 1,287
Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis
Pittayapruek, P., Meephansan, J., Prapapan, O., Komine, M., & Ohtsuki, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060868 · Cited by 1,099
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984
Morris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678
Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans
Park, J. S., Chyun, J. H., Kim, Y. K., Line, L. L., & Chew, B. P. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-18 · Cited by 569
Astaxanthin in Skin Health, Repair, and Disease: A Comprehensive Review
Davinelli, S., Nielsen, M. E., & Scapagnini, G. (2018) · Nutrients · doi:10.3390/nu10040522 · Cited by 473
Secondary ketocarotenoid astaxanthin biosynthesis in algae: a multifunctional response to stress
Lemoine, Y., & Schoefs, B. (2010) · Photosynthesis Research · doi:10.1007/s11120-010-9583-3 · Cited by 384
Galasko, D. R., Peskind, E., Clark, C. M., Quinn, J. F., Ringman, J. M., Jicha, G. A., Cotman, C., Cottrell, B., Montine, T. J., Thomas, R. G., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.85 · Cited by 377
Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease
Morris, M. C., Beckett, L. A., Scherr, P. A., Hebert, L. E., Bennett, D. A., Field, T. S., & Evans, D. A. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00001 · Cited by 332
Yoshida, H., Yanai, H., Ito, K., Tomono, Y., Koikeda, T., Tsukahara, H., & Tada, N. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.012 · Cited by 269
Cosmetic benefits of astaxanthin on humans subjects.
Tominaga, K., Hongo, N., Karato, M., & Yamashita, E. (2012) · Acta Biochimica Polonica · doi:10.18388/abp.2012_2168 · Cited by 248
Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease
Adair, J. C., Knoefel, J. E., & Morgan, N. (2001) · Neurology · doi:10.1212/wnl.57.8.1515 · Cited by 240
Ito, N., Seki, S., & Ueda, F. (2018) · Nutrients · doi:10.3390/nu10070817 · Cited by 141
OKADA, Y., ISHIKURA, M., & MAOKA, T. (2009) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.90078 · Cited by 94
Yoon, H.-S., Cho, H. H., Cho, S., Lee, S.-R., Shin, M.-H., & Chung, J. H. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.3060 · Cited by 93
Cited by
Saini, R. K., Prasad, P., Lokesh, V., Shang, X., Shin, J., Keum, Y.-S., & Lee, J.-H. (2022) · Antioxidants · doi:10.3390/antiox11040795 · Cited by 285
Rizvi, S. A. A., Einstein, G. P., Tulp, O. L., Sainvil, F., & Branly, R. (2022) · Biomolecules · doi:10.3390/biom12101442 · Cited by 181
“The main role of the pigment is to provide a desirable reddish color to the organisms reared, as most of them do not have access to natural carotenoids [116].”
BackgroundTechnological readiness of commercial microalgae species for foods
Yang, S., Fan, Y., Cao, Y., Wang, Y., Mou, H., & Sun, H. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2194423 · Cited by 47
Algal glycobiotechnology: omics approaches for strain improvement
Sirohi, R., Joun, J., Choi, H. I., Gaur, V. K., & Sim, S. J. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01656-6 · Cited by 39
Metadata
- Authors
- Donoso, A., González-Durán, J., Muñoz, A. A., González, P. A., & Agurto-Muñoz, C.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 166
- Pages
- 105479
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W3126793131
- Cited by
- 237
- References
- 18
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.